FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

e-Consent: An Idea Whose Time Has Come

Preview this audio conference


The following is a brief excerpt from this audio conference. Click on to play the sample. Please Contact Us with any questions you may have.



Audio conference highlights


This presentation discusses the key elements to consider in implementing e-informed consent. Based on currently implemented online trial consents, crucial steps in the implementation process will be described.


Drawing from current national and international trial experience with electronic multimedia informed consent and the research literature on multimedia consent, presenters will discuss key lessons learned concerning subject and trial characteristics that impact on implementation of electronic consent and its’ success in a clinical trial. The session discusses a decision path for determining if e-consent can be effectively implemented for a trial.


This audio conference covers:


  • Identifying the steps to implement online multimedia informed consent
  • Identifying the characteristics of online informed consent that are important to various subject groups
  • Identifying the types and locations of trials that work best with multimedia online consent
  • Best practices for implementing online multimedia informed consent


About the speakers:


Dr. Susan Brink founded ConsentSolutions, Inc. in 2005 to create and market innovative, media-based approaches to informed consent for clinical trials. With over 25 years of experience in research and development of patient and consumer health information products, Dr. Brink is a recognized expert in leveraging new technologies to support patient education and decision making. She is also the founder of HealthMark Multimedia, a company that designs and builds multimedia decision support tools for patients and caregivers.


Dr. Brink has published articles about methodologies for increasing the effectiveness of informed consent communications and is regularly invited to speak at national academic conferences. She has also acted as principal investigator on numerous NIH grants exploring technology approaches to patient decision making.


Jovianna DiCarlo has 19 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.


She is the President & Founder of AccuGenex Technologies, Inc. a consulting company providing services to venture capitalists to maximize ROI on life science investment portfolios. She actively contributes to technology application configuration & interface development, and the integration, adoption and implementation of intelligent technology applications to efficiently support biosurvelliance, clinical operations, and clinical research & development initiatives.


Who should attend?


  • Presidents and CEOs
  • Business Development Managers
  • e-Clinical & Technology Implementation Directors
  • Director, Global Clinical Outsourcing
  • Director, Clinical Research & Operations

Speaker & Time

Dr. Susan Brink, ConsentSolutions, Inc. & Jovianna DiCarlo, Accugenex Technologies, Inc.
e-Consent: An Idea Whose Time Has Come
Title: President & CEO, President
Duration: 60 minutes
Event Type: Previously recorded on 2008-12-03
Item #: ac20081203
3 Dec 2008 
Registration Price:
$249.00

Order Info

Select Order:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 4 reviews)

Showing 4 Reviews:

by S.B.
Study Manager
I saw some benefit of consenting patients using e-consents (ie, audio features as well as pictures), but still wasn't convinced it was much better then consenting patients using hardcopy consent.
by J.T.
Head of Patient Recruitment
A little frustrating at the beginning, had to hold on the line for 2-3mins before being spoken to by an operator, then had to answer a lot of questions before being placed in conference. Content was excellent, very relevant to my needs. Slides were a little confusing, speakers didn't state often enough which slide they were on, and some slides were not in the right place. They tended to jump about in what they were saying, so referneces were being made to future slides, and so I found myself going back and forth to find where we were at. However, that said, the material was useful.
by J.W.
Associate Director, Training
Consensus in our group audience is that the discussion took a little longer than necessary and the pace was a little slow.
by M.B.
Regional Trainer
I find the idea of an eICF to be a good one, and learned some great tips for future studies. The presentation was well thought out and the accompanying slides were appropriate for each topic discussed. I agree that additional audio/video/visual, etc. tools would enhance the subject's comprehension of the ICF. My only negative comment would be that during the Q & A session, it seemed to be more of a sales conference than a seminar.
Rate this item
Similar Events
Recruiting Research Participants Using Web-Based Software
Geoff Ott, mdlogix & Charles Rathmann, Washington University
More about Recruiting Research Participants Using Web-Based Software


More about Improving Patient Recruitment Through Better CRA Training


More about Integrating Data Streams for More Efficient Trials

 
Recently Viewed
The New MDD: 14 Things You Need to Know
Dr. Evangeline Loh, Emergo Group Inc.
More about The New MDD: 14 Things You Need to Know


Clinical Trial Success in Latin America
Dr. Federico Lerner, PRA International
More about Clinical Trial Success in Latin America


Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
Dr. Jerome Wilson & Kathleen Kushner, PRA International
More about Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting


Design and Regulatory Considerations in Anti-Infective Drug Development
Dr. John Powers, George Washington University School of Medicine & Dr. Carl Kraus, PRA International
More about Design and Regulatory Considerations in Anti-Infective Drug Development


More about Using SPL for Electronic Drug Establishment Registration & Drug Listing Submissions


Home  |   FAQ  |   Blog  |   Translation Services  |   Search  |   Privacy Policy  |   Terms of Use  |   Contact Us